Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 233 posts found.

shutterstock_92671375

Teva spared payout to GSK over patent infringement dispute

March 29, 2018
Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma

Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …

News
shutterstock_168864905

InSight Innovations to buy CureTech in $550m deal

March 28, 2018
Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

News
teva_copy

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

March 14, 2018
Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …

News
teva_copy

Migraine drug bad news hits a weakened Teva

February 9, 2018
Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …

News
20170105_studio_profielfoto___marco_avila_05_web

Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe

February 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …

Feature

Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets

January 30, 2018
Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma

Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …

News
teva_copy

More woes for Teva as two late-stage asthma studies bomb

January 23, 2018
Manufacturing and Production, Research and Development Teva, asthma, pharma

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …

News
teva_canada_1

FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia

January 16, 2018
Manufacturing and Production, Sales and Marketing FDA, Teva, acute promyelocytic leukaemia, leukaemia, pharma

Teva has announced that its Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with …

News
gavel_2

Teva settles with Israeli authorities over international bribery

January 15, 2018
Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …

News
teva_small

Teva execs feel the pinch, after pay halved

January 11, 2018
Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …

News
teva_copy

Fierce local opposition to Teva’s restructure efforts

December 15, 2017
Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …

News
teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017
Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023